
Incyte Corporation
INCY·NASDAQ
Last updated as of 2026-03-10 20:32 EST. Stock price information is sourced from TradingView and reflects real-time market prices.
Insights
Calculator
News
INCY stock price change
On the last trading day, INCY stock closed at 97.52 USD, with a price change of 0.43% for the day.
Trade stock perpsTrending stocks
About Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn moreINCY key data
Previous close97.52 USD
Market cap19.41B USD
Volume379.19K
P/E ratio15.23
Dividend yield (TTM)0.00%
Dividend amount-
Last ex-dividend date-
Last payment date-
EPS diluted (TTM)6.40 USD
Net income (FY)1.29B USD
Revenue (FY)5.14B USD
Next report dateMay 5, 2026
EPS estimate1.420 USD
Revenue estimate1.25B USD USD
Shares float196.97M
Beta (1Y)0.31

Incyte Corporation overview
Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas. The company was founded on April 8, 1991 and is headquartered in Wilmington, DE.
Sector
Health technology
Industry
Pharmaceuticals: Major
CEO
William J. Meury
Headquarters
Wilmington
Website
incyte.com
Founded
1991
Employees (FY)
2.84K
Change (1Y)
+227 +8.67%
Revenue / Employee (1Y)
1.81M USD
Net income / Employee (1Y)
452.41K USD
INCY Pulse
Daily updates on INCY stock prices, fund flows, and market news, generated by AI and reviewed by our team of analysts. Always DYOR.
See more
about 8h ago
See more
about 1D ago
INCY stock price forecast
According to technical indicators for INCY stock, the price is likely to fluctuate within the range of 108.27–125.48 USD over the next week. Market analysts predict that the price of INCY stock will likely fluctuate within the range of 102.73–137.47 USD over the next months.
Based on 1-year price forecasts from 83 analysts, the highest estimate is 253.34 USD, while the lowest estimate is 94.48 USD.
For more information, please see the
INCY stock price forecast
page.
Latest INCY stock news
Why Shares of Incyte (INCY) Are Rising Today
101 finance2026-01-14 21:42:29
Microsoft receives downgrade, Snap gets upgrade: Leading analyst picks from Wall Street
101 finance2026-02-05 15:21:33
Top Wall Street Analysts' Latest Ratings: Microsoft Downgraded, Snap Upgraded
新浪财经2026-02-05 16:47:07
Incyte (NASDAQ:INCY) Delivers Unexpected Q4 CY2025 Revenue Results
101 finance2026-02-10 13:21:14
Incyte: Fourth Quarter Earnings Overview
101 finance2026-02-10 12:30:06
Do financial experts on Wall Street have a favorable opinion of Incyte Corporation shares?
101 finance2026-02-12 11:33:43
Where is Incyte Corporation (INCY) Headed According to Analysts?
Finviz2026-02-19 14:57:45
Incyte Corp. (INCY) Reports Q4 2025 Revenue Growth of 28% to $1.51B Driven by Jakafi and Opzelura Sales
Finviz2026-02-20 09:12:44
Syndax Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Finviz2026-02-26 21:03:45
Syndax Pharmaceuticals Inc. (SNDX) on a Strong Footing amid Robust Demand for Key Flagship Drugs
Finviz2026-03-02 08:00:49
LLY Receives CHMP Approval for Broader Application of Olumiant in Treating Alopecia Areata
101 finance2026-03-02 17:49:21
Is Now a Good Moment to Include Labcorp Shares in Your Investment Portfolio?
101 finance2026-03-04 14:18:59
Is Now an Ideal Moment to Include Labcorp Shares in Your Investment Portfolio?
101 finance2026-03-04 14:18:59
INCY Receives European Commission Authorization to Broaden Zynyz Oncology Drug Indication
101 finance2026-03-09 17:18:49
MacroGenics Reports 2025 Financial Results and Highlights Upcoming Planned Data Disclosures
Finviz2026-03-09 20:06:46